Tonix Pharmaceuticals To Present Study Involving TNX-1500 At The American Transplant Congress 2024
Author: Benzinga Newsdesk | May 29, 2024 08:04am
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced two oral presentations and a poster presentation at the American Transplant Congress 2024, being held June 1-5, 2024 at the Pennsylvania Convention Center, Philadelphia, Pa. Details on each presentation can be found below.
Posted In: TNXP